Table 2:
Features of primary prevention of cervical cancer (HPV vaccination)
| Countries | HPV vaccination program (2020) | Related risk factors | ||||||
|---|---|---|---|---|---|---|---|---|
|
| ||||||||
| HPV vaccination in national immunization programs | Year of the introduction of HPV vaccination | Age of vaccination | Vaccine provision | Vaccine coverage (%)/Year | Tobacco use prevalence among women aged ≥ 15 years in 2020 (%) | Condom usage at last high-risk sex (%) | HIV incidence per 1000 women aged ≥ 15 yr in 2020 | |
| Malaysia | Yes | 2010 | 13 | Public/Private | 84 (2020) | 1 | ND | 0.06 |
| Thailand | Yes | 2017 | 11–12 | Public/Private | 66 (2019) | 4 | 76 | 0.05 |
| Iran | No | - | - | Private | ND | 3 | ND | 0.03 |
| Kenya | Yes | 2019 | 10 | Public/Private | 16 (2020) | 2 | 44 | 1.4 |
| Argentina | Yes | 2011 | 11 | Public/Private | 46 (2020) | 19 | ND | 0.09 |
| Ukraine | No | - | - | Private | ND | 9 | 80 | 0.2 |
Source: World Health Organization - Cervical Cancer Country Profiles, 2021
ND – No data